Male, n (%) | 122 (81.3%) |
---|---|
Age (years), mean (SD) | 72.9 (6.2) |
Months since diagnosis, median (IQR) | 6 (0–21) |
Smoking status | |
Current, n (%) | 9 (6.0%) |
Former, n (%) | 101 (67.3%) |
Never, n (%) | 40 (26.6%) |
Long-term oxygen therapy, n (%) | 19 (12.7%) |
Antifibrotic treatment, n (%)a | 85 (56.7%) |
FVC (% predicted), mean (SD) | 87.2 (23.1) |
DLCO (% predicted), mean (SD) | 48.4 (14.1) |
6MWD (m), mean (SD) | 450.3 (112.5) |
K-BILD total, mean (SD) | 58.3 (12.4) |
SGRQ-I total, mean (SD) | 42.9 (22.3) |
SOBQ, mean (SD) | 34.6 (25.3) |
SGRQ, mean (SD) | 40.8 (19.4) |